Pietro Rosellini

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 84 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer

Pietro Rosellini, Samuel Amintas, Charline Caumont et al. · European Journal of Cancer · 2022 · 43 citations

Somatic Variant, Stk11 Mutation, Medicine +8

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy

Edoardo Francini, Francesca Montagnani, Pier Vitale Nuzzo et al. · JAMA Network Open · 2021 · 17 citations · Full text

Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer

Giandomenico Roviello, Roberto Petrioli, Valerio Nardone et al. · Medicine · 2018 · 12 citations · Full text

.The Dof, First-line Therapy, Esophageal Cancer +11

Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer

Giandomenico Roviello, Silvia Paola Corona, Andrea Giovanni Multari et al. · Oncotarget · 2018 · 11 citations · Full text